leisure time -WSS

leisure time

author：fashion 2025-10-01 02:16:34 - browse：3186

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： Medical records are filled with copy
Next article： Why getting cancer drugs just got harder for rural patients

hotspot

WSS

Medical device lobby: We're tired of waiting on Medicare coverage

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

The pain doctors face in trying to build their families

FDA approves first treatment for ultra

How to address the problem of discarded donor organs

New definition of a human embryo proposed amid rapid advances

focus

leisure time

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

focus

Walensky prepares to leave CDC — and Congress — behind

As Maui death toll rises, number of missing remains unclear

Medical records are filled with copy

RSV vaccines may be linked to small increased risk of developing GBS

Hollywood unions extend contract negotiations for actors

House looks to weaken Medicare negotiation

Hepatitis C has a cure — but many Americans still lack access to it

An interview with Robert F. Kennedy Jr. on vaccines

Anesthesiologist group: stop taking Ozempic before surgery

Trump's false claims about Georgia's 2020 election long debunked

focus

RSV vaccines may be linked to small increased risk of developing GBS

Trump cancels press conference intended to dispute Georgia election interference charges

House looks to weaken Medicare negotiation

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Flu vaccine offering decent levels of protection this winter, new data show

Wikipedia

leisure time

hotspot

entertainment